scholarly article | Q13442814 |
P356 | DOI | 10.1097/TP.0B013E3181ABFBF7 |
P698 | PubMed publication ID | 19623014 |
P2093 | author name string | Harry Yang | |
Douglas Adkins | |||
Voravit Ratanatharathorn | |||
Barbara White | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | placebo | Q269829 |
P304 | page(s) | 198-202 | |
P577 | publication date | 2009-07-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease. | |
P478 | volume | 88 |
Q37123276 | High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. |
Q37881151 | Moving to tolerance: clinical application of T regulatory cells |
Q39948888 | Overcoming immunological barriers in regenerative medicine |
Q40852060 | Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model |
Q38066586 | Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation |
Q55506612 | The Role of Monoclonal Antibodies in the Management of Leukemia. |
Q33803804 | Transplantation immunology: solid organ and bone marrow |
Q37600436 | Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases |
Search more.